Relmada Therapeutics Other Long Term Assets (Quarterly) Trends

Relmada Therapeutics, Inc. (RLMD)

3.805 -0.14 (-3.43%) USD | NASDAQ | Jan 21, 16:00

3.805 0.00 (0.00%) After-Hours: 20:00

View Other Long Term Assets (Quarterly) for RLMD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	Upgrade
Invivyd, Inc.	Upgrade
Arcellx, Inc.	Upgrade
Puma Biotechnology, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade